Bosniak分类v2019 III类与IV类囊性肾脏肿物影像监测中的生长动力学与进展率
回顾性纳入105例患者共112个Bosniak v2019 III类或IV类囊性肾肿物,在基线肾脏肿物CT或MRI方案检查后行主动监测。IV类肿物中位线性生长率高于III类(2.3 mm/y vs 0.0 mm/y,p<.001),进展发生率更高(每10万人日73.6 vs 11.0),进展风险为III类的5.1倍(HR 5.1,95%CI 2.5-10.8,p<.001)。
要点
- Bosniak v2019 IV类囊性肾肿物中位线性生长率为2.3 mm/y,III类为0.0 mm/y(p<.001)。
- 线性生长率≥5 mm/y者III类占7%(4/58),IV类占28%(15/54)(p=.005)。
- IV类相对III类的进展风险比为5.1(95%CI 2.5-10.8,p<.001)。
核心结论
- 在Bosniak v2019分类评估的囊性肾肿物主动监测中,IV类肿物较III类生长更快且更易进展。
研究设计与样本
- 回顾性研究纳入105例患者(68男、37女,中位年龄67岁)共112个Bosniak v2019 III类或IV类囊性肾肿物,基线为2005年1月至2021年9月期间行肾脏肿物方案CT或MRI检查。
诊断标准与关键数值
- 进展定义为线性生长率≥5 mm/y(临床指南干预阈值)、体积倍增时间<1年、T分期升高或N1/M1病变;基线III类58个、IV类54个;中位随访403天。
临床应用与阅片要点
- 作者认为,与现行将III类和IV类肿物同等对待的主动监测指南相比,未来版本可能对IV类肿物采用相对更密集的监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Active surveillance is increasingly used as first-line management for localized renal masses. Triggers for intervention primarily reflect growth kinetics, which have been poorly investigated for cystic masses defined by the Bosniak classification version 2019 (v2019). OBJECTIVE. The purpose of this study was to determine growth kinetics and incidence rates of progression of class III and IV cystic renal masses, as defined by the Bosniak classification v2019. METHODS. This retrospective study included 105 patients (68 men, 37 women; median age, 67 years) with 112 Bosniak v2019 class III or IV cystic renal masses on baseline renal mass protocol CT or MRI examinations performed from January 2005 to September 2021. Mass dimensions were measured. Progression was defined as any of the following: linear growth rate (LGR) of 5 mm/y or greater (representing the clinical guideline threshold for intervention), volume doubling time less than 1 year, T category increase, or N1 or M1 disease. Class III and IV masses were compared. Time to progression was estimated using Kaplan-Meier curve analysis. RESULTS. At baseline, 58 masses were class III and 54 were class IV. Median follow-up was 403 days. Median LGR for class III masses was 0.0 mm/y (interquartile range [IQR], -1.3 to 1.8 mm/y) and for class IV masses was 2.3 mm/y (IQR, 0.0-5.7 mm/y) (p < .001). LGR was at least 5 mm/y in four (7%) class III masses and 15 (28%) class IV masses (p = .005). Two patients, both with class IV masses, developed distant metastases. Incidence rate of progression for class III masses was 11.0 (95% CI, 4.5-22.8) and for class IV masses 73.6 (95% CI, 47.8-108.7) per 100,000 person-days of follow-up. Median time to progression was undefined for class III masses given the small number of progression events and 710 days for class IV masses. Hazard ratio of progression for class IV relative to class III masses was 5.1 (95% CI, 2.5-10.8; p < .001). CONCLUSION. During active surveillance of cystic masses evaluated using the Bosniak classification v2019, class IV masses grew faster and were more likely to progress than class III masses. CLINICAL IMPACT. In comparison with current active surveillance guidelines that treat class III and IV masses similarly, future iterations may incorporate relatively more intensive surveillance for class IV masses.
引用
- Tse, Shen, Shen, et al. Growth Kinetics and Progression Rate of Bosniak Classification Version 2019 Class III and IV Cystic Renal Masses on Imaging Surveillance. AJR Am J Roentgenol. 2022. PMID: 35293234. doi:10.2214/AJR.22.27400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。